Paper40693239
Global burden of female breast cancer: new estimates in 2022, temporal trend and future projections up to 2050 based on the latest release from GLOBOCAN.
Zhang Y and 16 others. J Natl Cancer Cent, 2025. Cited by 143 papers, by iCite.
Cite this record
ConductScience Library. Global burden of female breast cancer: new estimates in 2022, temporal trend and future projections up to 2050 based on the latest release from GLOBOCAN. Papers, record 40693239. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40693239
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Global burden of female breast cancer: new estimates in 2022, temporal trend and future projections up to 2050 based on the latest release from GLOBOCAN.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Trials2
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record | Source |
|---|---|---|---|---|
| NCT07344597 | Prospective Comparative Study of Hypofractionated Adjuvant Radiotherapy in 2 Virsus 3 Weeks in Breast Cancer | Results | ClinicalTrials.gov | |
| NCT07367334 | Effects of MMV Exercise With and Without Verbal Guidance on Shoulder Movement, Fatigue, and Stress in Breast Cancer Survivors | Results | ClinicalTrials.gov |
References70
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 38762325 | Burden of disease scenarios for 204 countries and territories, 2022-2050: a forecasting analysis for the Global Burden of Disease Study 2021. | Lancet | 2024 | https://conductscience.org/library/papers/38762325 | PubMed |
| 2 | 32679112 | Fertility, mortality, migration, and population scenarios for 195 countries and territories from 2017 to 2100: a forecasting analysis for the Global Burden of Disease Study. | Lancet | 2020 | https://conductscience.org/library/papers/32679112 | PubMed |
| 3 | 36883419 | Breast cancer screening programmes and self-reported mammography use in European countries. | Int J Cancer | 2023 | https://conductscience.org/library/papers/36883419 | PubMed |
| 4 | 33691141 | The Global Breast Cancer Initiative: a strategic collaboration to strengthen health care for non-communicable diseases. | Lancet Oncol | 2021 | https://conductscience.org/library/papers/33691141 | PubMed |
| 5 | 31030667 | Current cancer situation in China: good or bad news from the 2018 Global Cancer Statistics? | Cancer Commun (Lond) | 2019 | https://conductscience.org/library/papers/31030667 | PubMed |
| 6 | 22456983 | Breast cancer incidence trends in European women aged 20-39 years at diagnosis. | Breast Cancer Res Treat | 2012 | https://conductscience.org/library/papers/22456983 | PubMed |
| 7 | 37774721 | Quantitative estimates of preventable and treatable deaths from 36 cancers worldwide: a population-based study. | Lancet Glob Health | 2023 | https://conductscience.org/library/papers/37774721 | PubMed |
| 8 | 31933580 | National Breast Screening Programs across Europe. | Breast Care (Basel) | 2019 | https://conductscience.org/library/papers/31933580 | PubMed |
| 9 | 17442911 | The decrease in breast-cancer incidence in 2003 in the United States. | N Engl J Med | 2007 | https://conductscience.org/library/papers/17442911 | PubMed |
| 10 | 34002584 | Breast cancer incidence and mortality in women in China: temporal trends and projections to 2030. | Cancer Biol Med | 2021 | https://conductscience.org/library/papers/34002584 | PubMed |
| 11 | 28988610 | Trends and predictions to 2020 in breast cancer mortality in Europe. | Breast | 2017 | https://conductscience.org/library/papers/28988610 | PubMed |
| 12 | 38572751 | Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. | CA Cancer J Clin | 2024 | https://conductscience.org/library/papers/38572751 | PubMed |
| 13 | 34062485 | European trends in breast cancer mortality, 1980-2017 and predictions to 2025. | Eur J Cancer | 2021 | https://conductscience.org/library/papers/34062485 | PubMed |
| 14 | 24639443 | Temporal trends of main reproductive characteristics in ten urban and rural regions of China: the China Kadoorie biobank study of 300 000 women. | Int J Epidemiol | 2014 | https://conductscience.org/library/papers/24639443 | PubMed |
| 15 | 32933761 | Landmark trials in the medical oncology management of early stage breast cancer. | Semin Oncol | 2020 | https://conductscience.org/library/papers/32933761 | PubMed |
| 16 | 10793111 | Biologic characteristics of interval and screen-detected breast cancers. | J Natl Cancer Inst | 2000 | https://conductscience.org/library/papers/10793111 | PubMed |
| 17 | 38000379 | Cancer screening in China: a steep road from evidence to implementation. | Lancet Public Health | 2023 | https://conductscience.org/library/papers/38000379 | PubMed |
| 18 | 34278281 | Global breast cancer incidence and mortality trends by region, age-groups, and fertility patterns. | EClinicalMedicine | 2021 | https://conductscience.org/library/papers/34278281 | PubMed |
| 19 | 12117397 | Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. | JAMA | 2002 | https://conductscience.org/library/papers/12117397 | PubMed |
| 20 | 10580027 | Breast tumor characteristics as predictors of mammographic detection: comparison of interval- and screen-detected cancers. | J Natl Cancer Inst | 1999 | https://conductscience.org/library/papers/10580027 | PubMed |
Cited by113
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 143 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42985087 | Burden, trends, and projections of prostate cancer: global cancer statistics (GLOBOCAN) estimates for 2024 and 2022. | J Natl Cancer Cent | 2026 | https://conductscience.org/library/papers/42985087 | PubMed |
| 42955935 | Reported clinical breast examination activity in Bangladesh, 2019-2025: Temporal trends, geographic variation, positivity, and reporting completeness. | PLoS One | 2026 | https://conductscience.org/library/papers/42955935 | PubMed |
| 42952764 | Harnessing marine polysaccharides for breast cancer therapy: ulvan synergizes with nano-selenium to induce programmed cell death through dual modulation of autophagy and apoptosis. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42952764 | PubMed |
| 42941599 | A Comparative Analysis of Women's Experiences with Cone Beam Breast CT and Digital Mammography in Australia. | J Clin Med | 2026 | https://conductscience.org/library/papers/42941599 | PubMed |
| 42923786 | Design and synthesis of 3-(1H-indol-3-yl)-N-(3,4,5-trimethoxyphenyl) acrylamide derivatives as anticancer agents. | RSC Adv | 2026 | https://conductscience.org/library/papers/42923786 | PubMed |
| 42877267 | Determinants of self-reported sustained breast cancer screening among women in Shenzhen, China: a study based on the health belief model. | Front Public Health | 2026 | https://conductscience.org/library/papers/42877267 | PubMed |
| 42830884 | VEGF-Leptin Crosstalk in Breast and Ovarian Cancer: Drivers of Angiogenesis and Progression. | Cancer Manag Res | 2026 | https://conductscience.org/library/papers/42830884 | PubMed |
| 42820989 | Development of ursolic acid-loaded cubosomal nanocarriers: enhanced dissolution, pharmacokinetics, bioavailability, and anticancer activity. | Naunyn Schmiedebergs Arch Pharmacol | 2026 | https://conductscience.org/library/papers/42820989 | PubMed |
| 42798422 | In vivo assessment of broccoli extract based hydrogel in mitigating DMBA induced breast cancer in female mice. | Front Oncol | 2026 | https://conductscience.org/library/papers/42798422 | PubMed |
| 42786286 | Localized immunotherapy via dissolving microneedles for the prevention of breast cancer recurrence. | Drug Deliv Transl Res | 2026 | https://conductscience.org/library/papers/42786286 | PubMed |
| 42755039 | Synthesis, Structural Characterization, and Investigation of Biological Effects of Novel Benzothiazole-Triazole Derivatives Designed as AKT Kinase Inhibitors. | Chem Biol Drug Des | 2026 | https://conductscience.org/library/papers/42755039 | PubMed |
| 42738331 | Comprehensive Genomic Profiling Reveals the Mutational Spectrum and Clinical Significance of BRCA1/2 and Other Cancer-Susceptibility Genes in Breast Cancer Patients from Southern Tunisia. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42738331 | PubMed |
| 42717684 | Knowledge of early signs and risk factors, and attitude towards breast cancer among women in Dodoma, Tanzania: a community-based cross-sectional study. | Future Sci OA | 2026 | https://conductscience.org/library/papers/42717684 | PubMed |
| 42707088 | Comorbidity patterns and risk of breast cancer: a case-control study exploring interaction with BMI using latent class analysis. | Front Oncol | 2026 | https://conductscience.org/library/papers/42707088 | PubMed |
| 42699527 | Integrin α3 (ITGA3) expression across breast cancer subtypes: Prognosis and therapeutic relevance. | Cancer Pathog Ther | 2026 | https://conductscience.org/library/papers/42699527 | PubMed |
| 42670587 | Superantigens in Cancer Immunotherapy: Mechanisms, Engineering Strategies, and Therapeutic Potential. | FASEB J | 2026 | https://conductscience.org/library/papers/42670587 | PubMed |
| 42652383 | Breast Cancer Knowledge and Screening Barriers Among Female University Students of Pakistan. | Int J Environ Res Public Health | 2026 | https://conductscience.org/library/papers/42652383 | PubMed |
| 42651307 | Algorithmic Prognostication in Female Oncofertility Counseling: Ethical Challenges of Bias, Autonomy, and Predictive Uncertainty. | Healthcare (Basel) | 2026 | https://conductscience.org/library/papers/42651307 | PubMed |
| 42605911 | Venom-Derived Peptides in Breast Cancer: Pharmacological Mechanisms and Medicinal Chemistry-Guided Translational Development. | Arch Pharm (Weinheim) | 2026 | https://conductscience.org/library/papers/42605911 | PubMed |
| 42591577 | Emerging role of human epidermal growth factor 2-low status in the prognosis and management of triple-negative breast cancer: a narrative review. | Transl Cancer Res | 2026 | https://conductscience.org/library/papers/42591577 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40693239
GET https://conductscience.org/api/papers/v1/40693239/references?page=2